Vantage Orian
Payments companies reported to CMS as associated with Vantage Orian. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vantage Orian, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vantage Orian
These are the largest totals companies reported as associated with Vantage Orian. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kanae Mukai | Salinas, CA | Cardiovascular Disease | $7,654.46 |
| Brent Weinberg | Atlanta, GA | Neuroradiology | $4,200.00 |
| Kirti Kulkarni | Chicago, IL | Diagnostic Radiology | $3,750.00 |
| Peter Chang | San Francisco, CA | Neuroradiology | $2,000.00 |
| Hoang Nguyen | Sartell, MN | Diagnostic Radiology | $1,644.02 |
| Alan Alexander | Los Angeles, CA | Diagnostic Radiology | $1,358.61 |
| Joshua Rosebrook | West Des Moines, IA | Diagnostic Radiology | $1,162.83 |
| Brian Tsui | San Francisco, CA | Diagnostic Radiology | $769.57 |
| Jason Lance | Ogden, UT | Diagnostic Radiology | $521.25 |
| Michael Dantonio | Marrero, LA | Diagnostic Radiology | $474.26 |
Prescribed Vantage Orian?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.